Do Pharmaceutical Mergers Harm Drug Innovation?

Business & Finance
Cover of the book Do Pharmaceutical Mergers Harm Drug Innovation? by Jan Schmidt, GRIN Verlag
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Jan Schmidt ISBN: 9783656962168
Publisher: GRIN Verlag Publication: May 15, 2015
Imprint: GRIN Verlag Language: English
Author: Jan Schmidt
ISBN: 9783656962168
Publisher: GRIN Verlag
Publication: May 15, 2015
Imprint: GRIN Verlag
Language: English

Master's Thesis from the year 2013 in the subject Business economics - Miscellaneous, grade: 8,5 (NL, äquivalent zu 1,2), Utrecht University (Law, Economics and Governance), course: Mergers & Akquisitions, language: English, abstract: The number and volume of pharmaceutical companies' mergers and acquisitions have reached exorbitant magnitudes in the last decade, with estimations of over 1,300 deals worth US$ 690 billion between 2000 and 2009.1 The biggest transaction, valued at US$ 66.7 billion2, occurred in 2009 when Pfizer bought Wyeth. The sheer dimension of transactions in this sector, being subject to significant public interest, poses questions about the motivations behind these deals, which are mostly believed to be countermeasures for patent expirations, as well as the impact on drug innovation. Even though, the regular object of interest regarding mergers is the shareholder value, in this specific case drug innovation is of particular interest as it does not only influence the future prospects of the pharmaceutical companies but also long term public health. Hence, the objective of this thesis is to discover what the impact of pharmaceutical mergers on R&D intensity and efficiency of the acquiring organization and on the pharmaceutical industry as a whole is.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Master's Thesis from the year 2013 in the subject Business economics - Miscellaneous, grade: 8,5 (NL, äquivalent zu 1,2), Utrecht University (Law, Economics and Governance), course: Mergers & Akquisitions, language: English, abstract: The number and volume of pharmaceutical companies' mergers and acquisitions have reached exorbitant magnitudes in the last decade, with estimations of over 1,300 deals worth US$ 690 billion between 2000 and 2009.1 The biggest transaction, valued at US$ 66.7 billion2, occurred in 2009 when Pfizer bought Wyeth. The sheer dimension of transactions in this sector, being subject to significant public interest, poses questions about the motivations behind these deals, which are mostly believed to be countermeasures for patent expirations, as well as the impact on drug innovation. Even though, the regular object of interest regarding mergers is the shareholder value, in this specific case drug innovation is of particular interest as it does not only influence the future prospects of the pharmaceutical companies but also long term public health. Hence, the objective of this thesis is to discover what the impact of pharmaceutical mergers on R&D intensity and efficiency of the acquiring organization and on the pharmaceutical industry as a whole is.

More books from GRIN Verlag

Cover of the book Interaktion und Interaktionsanalyse in Erziehung und Unterricht by Jan Schmidt
Cover of the book Kurze Geschichte der Hochgeschwindigkeitsfotografie sowie die ästhetische Wirkung by Jan Schmidt
Cover of the book Grenzen des Teamrollenmodells nach Belbin in der Praxis by Jan Schmidt
Cover of the book Raumlage mit Roland dem Hasen by Jan Schmidt
Cover of the book Vor- und Nachteile von Diversity-Konzepten by Jan Schmidt
Cover of the book Soziale Angst und Soziale Phobie by Jan Schmidt
Cover of the book Social Change and the Picture of Time by Jan Schmidt
Cover of the book Systemische Therapie und Beratung in Theorie und Praxis by Jan Schmidt
Cover of the book Der Prozess der Globalisierung by Jan Schmidt
Cover of the book Nubi - Eine arabische Kreolsprache in Uganda by Jan Schmidt
Cover of the book Strategic Change Management. Workbased Assignment for Diploma in Strategic Leadership (DSM/MBA) by Jan Schmidt
Cover of the book Ausgewählte Konzepte von Inklusion in der schulischen Praxis. Wie können Kinder und Jugendliche mit Gefühls- und Verhaltensstörungen bestmöglich gefördert werden? by Jan Schmidt
Cover of the book Standardsetter - ein Vergleich der Institutionen in Deutschland und den USA by Jan Schmidt
Cover of the book Zielgruppen der Suchtprävention by Jan Schmidt
Cover of the book Märchen erzählen mit dem Kamishibai by Jan Schmidt
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy